G. Hunter Myers, MD, FACC

Subspecialty Education Director, Cardiology


EDUCATION
Undergraduate: University of Virginia, Charlottesville, VA – Bachelor of Arts
Medical School: University of Virginia School of Medicine, Charlottesville, VA
Residency: Internal Medicine – University of North Carolina Hospitals, Chapel Hill, NC
Chief Residency: Internal Medicine – University of North Carolina Hospitals, Chapel Hill, NC
Fellowship: Cardiology – University of North Carolina Hospitals, Chapel Hill, NC

PROFESSIONAL ORGANIZATIONS
Member, American Medical Association
Member, Medical Association of Georgia
Fellow, American College of Cardiology
Fellow, Society for Cardiovascular Angiography and Intervention

PUBLICATIONS
Jain, A., Hicks, R.R., Frantz, D.M., Myers, G.H., & Rowe, M.W. (1990). Comparison of early exercise treadmill test and oral dipyridamole thallium-201 tomography for the identification of jeopardized myocardium in patients receiving thrombolytic therapy for acute Q-wave myocardial infarction. American Journal of Cardiology, 66, 551-55.

Jain, A., Hicks, R.R., Myers, G.H., McCarthy, J.J., Pery, J.R., & Adams, K.F. (1990).  Comparison of coronary angiography and early oral dipyridamole thallium-201 scintigraphy for acute myocardial infarction.  American Heart Journal, 120, 839-47.

Jain, A, Myers, G.H., Rowe, M.W., Dehmer, G.J., & Robinson, D.S. (1991). Comparisons of coronary angiographic features and oral dipyridamole thallium-201 tomography. Angiology, 42, 99-105.

Myers, G.H., Hansen, T.H., & Jain, A. (1991). Left main coronary artery and femoral artery vasospasm associated with cocaine use. Chest.

Myers, G.H., Sapin, P.M., & Jain, A. (1991). Is coronary angiography necessary in patients requiring repeat cardiac valve surgery? American Journal of Cardiology.

Jain, A., Frantz, D., Rowe, M.W., & Myers, G.H. (1990). Abstract: Comparison of oral dipyridamole and exercise treadmill test after thrombolytic therapy. Clinical Research, 38, 246A. (Presented)

Jain, A., Sapin, P., & Myers, G.H. (1991). Abstract: Direction of ST segment shift during pacing and balloon angioplasty. Clinical Research, 39, 400A.

RESEARCH
Global Use of Strategies to Open Occluded Coronary Arteries in Acute  Coronary Syndromes (GUSTO II and III). Sub-Investigator 1994-96.

Use of Accupril in Cardiomyopathy (ACHIEVE). Principal Investigator

Antiarrhythmic Drug Study in the post-MI patient, 21 day window.  Patients followed for 13 months.  June 1998-November 2000, 6 patients.  Role: Principal Investigator

New Drug for the Treatment of Acute Coronary Syndrome without ST-segment elevation.  1998-May 1999, 2 patients. Role: Principal Investigator
Thrombolytic in Acute MI, 6 hour window.  Patients followed for one year.  August 1998-November 1998, 1 patient.  Role: Principal Investigator

Phase III Study to Evaluate the Outcome of Patients Treated with a Study Drug Targeting Reduction of Inflammation Preventing Coronary Events.   Patients followed for 24 months.  January 2004- present. Investigators: Hunter Myers, MD (PI); Michael Ware, MD; Vincent Pearson, MD; Hector Picon, MD; Alfonso Diaz, MD; Gwynne Floyd, MD; Frank Stegall, MD; Raymond Young, MD, Robert Styperek, MD, Nasser Tehrani, MD, Chris Merritt, MD.

Phase III Antiplatelet Drug Study in Acute Coronary Syndrome.  Patients followed for at least one year.  December 1998-June 1999, 2 patients. Investigators: Hunter Myers, MD (PI); Michael Ware, MD; Vincent Pearson, MD; Hector Picon, MD; Alfonso Diaz, MD; Gwynne Floyd, MD; Frank Stegall, MD; Raymond Young, MD

Phase IV Registry of Cardiac Resynchronization Therapy in Heart Failure Patients.  Patients followed for 12 months.  May 2003-present, 3 patients (30% enrollment). Investigators:  Vincent Pearson, MD (PI); Hunter Myers, MD; Michael Ware, MD; Hector Picon, MD; Alfonso Diaz, MD; Gwynne Floyd, MD; Frank Stegall, MD; Raymond Young, MD; Timothy McDermott, MD; Robert P. Styperek, MD

Randomized controlled trial to evaluate the safety and efficacy of a coronary filter system in subjects with a restenotic lesion of saphenous vein grafts.  Patients followed for 30 days.  September 2003-present, 11 patients. Investigators: Frank Stegall, MD (PI); Hunter Myers, MD; Michael Ware, MD; Nasser Tehrani, MD; Hector Picon, MD; Gwynne Floyd, MD; Raymond Young, MD

DAPT Study.  Completed 2014.  Role:  Principal investigator at Redmond.

SAVI Study.  Ongoing study.  Role:  Sub-principal investigator.

G. Hunter Myers, MD, FACC